CareDx Partners with the National Kidney Foundation to Advocate for Kidney Transplant PatientsGlobeNewsWire • 03/02/22
CareDx, Inc (CDNA) CEO Reg Seeto on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/25/22
On National Donor Day, CareDx Applauds Patient Advocacy Efforts Aimed at Increasing Donations for the Thousands of Patients Waiting for a TransplantGlobeNewsWire • 02/14/22
CareDx Joins Forces with MOTTEP, The National Minority Organ Tissue Transplant Education Program, to Host “Heart Health” Webinar for Transplant PatientsGlobeNewsWire • 02/07/22
Landmark ADMIRAL Study Publication with CareDx's AlloSure Kidney is the First Long-Term Multicenter Prospective Clinical Validation for Routine Organ Transplant SurveillanceGlobeNewsWire • 01/12/22
NIH Study Shows Using CareDx's AlloSure Lung for Transplant Surveillance is More Effective than Diagnostic Bronchoscopy at Identifying RejectionGlobeNewsWire • 01/07/22
CareDx Successfully Completes CLIA Validation of AlloMap Kidney in Preparation for Commercial LaunchGlobeNewsWire • 01/06/22
CareDx Expands Its Medication Adherence Services with the Acquisition of The Transplant PharmacyGlobeNewsWire • 01/05/22
CareDx: Short-Term Headwinds Will Pass, Longer-Term High Growth Investment Case RemainsSeeking Alpha • 01/05/22
ROSEN, A TOP RANKED LAW FIRM, Encourages CareDx, Inc. Investors with Losses to Inquire About Securities Class Action Investigation - CDNAPRNewsWire • 12/19/21
CareDx Enrolls First Patient in LungCare Registry Study to Measure Impact of Multimodality Assessment on Lung Transplant Patient OutcomesGlobeNewsWire • 12/16/21
CDNA Shareholder Alert: Rosen, Top Ranked Global Investor Counsel, Encourages CareDx, Inc. Investors with Losses in Excess of $100K to Inquire About Securities Class Action Investigation - CDNANewsfile Corp • 12/08/21
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages CareDx, Inc. Investors to Inquire About Securities Class Action Investigation - CDNAPRNewsWire • 12/07/21
ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against CareDx, Inc and Encourages Investors with Losses to Contact the FirmNewsfile Corp • 12/04/21
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CareDx (CDNA) Investors with Significant Losses to Contact Firm's Attorneys, Firm Investigating Possible Securities Law ViolationsNewsfile Corp • 11/26/21
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against CareDx, Inc and Encourages Investors with Losses to Contact the FirmPRNewsWire • 11/24/21